The pharmaceutical side of psychedelics
Alejandro Antalich
Chief Executive Officer & Director
Mr. Antalich is the former Chief Executive Officer of ICC Labs Inc. (TSXV), the first publicly traded company in the world to sell cannabis to a federal government. Through strategic foresight, determination, commitment, responsibility, teamwork and passion, he led ICC Labs to its successful sale to Aurora Cannabis (TSX) in November 2018. An entrepreneur with a commercial instinct and vision towards business growth, with expertise in the pharmaceutical industry, operations, manufacturing and product development. A savvy negotiator that manages unique relationship building skills. He led the negotiations of a multimillion transaction with one of the largest participants in the cannabis industry.
Oscar León
Chief Financial Officer & Director
A highly experienced Certified Public Accountant with a solid background in Financial Management, Accounting, Project Finance and Risk Analysis, with experience in Agriculture, Cannabis, Mining and Hydropower Industries.
US/Canadian GAAP, IFRS knowledge, SEC and TSX reporting and filing experience.
Strong sense of teamwork, quality and ethics.
A results-oriented individual who demonstrates his abilities to the benefit of the organization. 3+ decades of experience as Certified Public Accountant. 2+ decades of experience as CFO, Financial Controller, Chief Accountant for several Uruguayan, Canadian and American Companies.
Juan Presa
Chief Legal Officer
Attorney at law from the Catholic University in Uruguay, specializing in corporate, commercial and international law. Juan has worked with companies from diverse industries such as agriculture, mining, cannabis, FinTech, including listed companies both on the New York Stock Exchange and the Toronto Stock Exchange.
Juan developed the business expansion of companies through South America, Asia-Pacific and Africa, and participating in mergers and acquisitions of both public and private companies, public offerings and private placement financings.
Draulio Barros de Araujo, PhD
Scientific and Clinical Advisor
.